These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11884485

  • 41. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
    Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N, Beck-Sickinger A, von Hörsten S, Yamamura T.
    J Immunol; 2003 Oct 01; 171(7):3451-8. PubMed ID: 14500640
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE).
    Munro KM, Dixon KJ, Gresle MM, Jonas A, Kemper D, Doherty W, Fabri LJ, Owczarek CM, Pearse M, Boyd AW, Kilpatrick TJ, Butzkueven H, Turnley AM.
    PLoS One; 2013 Oct 01; 8(2):e55948. PubMed ID: 23390555
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H, Zhang H, Liu F, Qi Y, Jiang H.
    Immunol Lett; 2014 Oct 01; 157(1-2):38-44. PubMed ID: 24220208
    [Abstract] [Full Text] [Related]

  • 49. IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis.
    Weir C, Bernard CC, Bäckström BT.
    Int Immunol; 2003 Nov 01; 15(11):1283-9. PubMed ID: 14565926
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
    Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, Lehmann-Horn K, Danilenko DM, Eastham-Anderson J, Slavin AJ, Linington C, Bernard CC, Martin F, Zamvil SS.
    Ann Neurol; 2010 Sep 01; 68(3):369-83. PubMed ID: 20641064
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M, Li YT, Sorokin L, Rottner K, Vestweber D.
    J Neurosci; 2020 Feb 12; 40(7):1389-1404. PubMed ID: 31911458
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease.
    Visser L, Jan de Heer H, Boven LA, van Riel D, van Meurs M, Melief MJ, Zähringer U, van Strijp J, Lambrecht BN, Nieuwenhuis EE, Laman JD.
    J Immunol; 2005 Jan 15; 174(2):808-16. PubMed ID: 15634902
    [Abstract] [Full Text] [Related]

  • 57. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A, Sahu SK, Wu Y, Zaheer A, Haas J, Lee K, Yang B.
    Brain Res; 2007 May 04; 1144():239-47. PubMed ID: 17316572
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.